Ayala Pharmaceuticals Announces Continuation of RINGSIDE Phase 2/3 Study in Desmoid Tumors Following Recommendation of Independent Data Monitoring Committee

Provided By Globe Newswire

Last update: Mar 3, 2023

Registration-enabling Phase 3 segment of RINGSIDE is enrolling patients globally

Updated data on AL102 Phase 2 segment of RINGSIDE are planned for presentation at a medical meeting in 2023